A RCT to Assess the Performance of CytoSorb for Shock Reversal in Patients With Vasoplegic Septic Shock
Clinical trial NCT04963920 · SUSPENDED
Trial details
- NCT number
- NCT04963920
- Sponsor
- CytoSorbents Europe GmbH
- Status
- SUSPENDED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-30
- Primary completion
- 2027-02-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.